SecBot SecBot

TKNO

Alpha Teknova, Inc.
Nasdaq· In Vitro & In Vivo Diagnostic Substances· Inc. DE· CIK 0001850902 Biotech & Drug Discovery
$6.45 +0.03 (+0.40%)
Oct 26 4:00 PM ET · prev $6.42
Market cap
$379.5M
Small cap
Consensus
Buy
86% Buy or better · 14 analysts
Median target
$9.50
+47% · range $8.00–12.00
Next earnings
Nov 4
in 9 days · EPS est. −$0.07
1 year
+18.3%
from $5.45 · Oct 27
30 days
−29.9%
from $9.20
52-week range
$1.99–9.33
−31% from high · low Feb 17
Avg volume 20D
639.6K
Oct 21 spike 5.72M
Short interest
1.63M
≈3.0% of shares · +3.5%
Days to cover
4.8
at average volume
Insider net
+$143.4K
2 buyers · 0 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
SecBot read BEARISH 6 reports · 90 days
Balance 3 bearish · 0 bullish · 2 mixed · 1 neutral oldest → newest, height = score
Avg score ·High conf. 3/6 ·Next Earnings date, Nov 4, 2026

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    2 insiders bought $143.4K at an average $2.17. No open-market sales. Price is 197% above their cost.

  • InstitutionsBULLISH

    Q2 2026: 14 added (0 new), 5 trimmed or exited.

  • AnalystsBULLISH

    12 of 14 rate it Buy or better. Every target is above the price.

  • EstimatesRISING

    Current-quarter EPS estimate −$0.082 → −$0.070 over 90 days. 4 up, 1 down in 30 days.

  • Short sellersSTEADY

    Short interest +3.5% to 1.63M shares. 4.8 days to cover, ≈3.0% of shares.

  • TrendDOWNTREND

    16% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
ROYCE & ASSOCIATES LPADD1,661,395$9.4M
VANGUARD CAPITAL MANAGEMENT LLCDOUBLED1,614,045$9.2M
UBS Group AGADD631,967$3.6M
GOLDMAN SACHS GROUP INCADD172,017$977.1K
VANGUARD FIDUCIARY TRUST COADD103,467$587.7K
MILLENNIUM MANAGEMENT LLCNEAR_EXIT74,966$425.8K
WELLS FARGO & COMPANY/MNDOUBLED69,225$393.2K
JANE STREET GROUP, LLCTRIM36,847$209.3K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

14 analysts
Buy 86% rate it Buy or better
Strong Buy6Buy6Hold2Sell0Strong Sell0
12-month targets · 6 analysts

Price is below the lowest target. Median implies +47%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
Oct 13, 2026TD Cowen
MAINTAIN
MAINTAINBuy
Sep 17, 2026Jefferies
INITIATE
INITIATEBuy
Aug 11, 2026BTIG
UPGRADE
UPGRADEBuy
Aug 5, 2026Roth Capital
INITIATE
INITIATEBuy
Congressional trades
TKNO trades disclosed by members of Congress, with disclosure delay.
1 members · 1 buys / 60 sells
DateMemberTypeAmountDisclosed
Aug 12, 2026
Richard Blumenthal
D· SENATE· ALPHA TEKNOVA INC
SELL$1,001 - $15,000Sep 1, 2026(21d)
Aug 12, 2026
Richard Blumenthal
D· SENATE· ALPHA TEKNOVA INC
SELL$1,001 - $15,000Sep 1, 2026(21d)
Aug 11, 2026
Richard Blumenthal
D· SENATE· ALPHA TEKNOVA INC
SELL$1,001 - $15,000Sep 1, 2026(22d)
Aug 11, 2026
Richard Blumenthal
D· SENATE· ALPHA TEKNOVA INC
SELL$15,001 - $50,000Sep 1, 2026(22d)
Aug 10, 2026
Richard Blumenthal
D· SENATE· ALPHA TEKNOVA INC
BUY$1,001 - $15,000Sep 1, 2026(23d)
Aug 10, 2026
Richard Blumenthal
D· SENATE· ALPHA TEKNOVA INC
SELL$1,001 - $15,000Sep 1, 2026(23d)
Aug 7, 2026
Richard Blumenthal
D· SENATE· ALPHA TEKNOVA INC
SELL$15,001 - $50,000Sep 1, 2026(26d)
Aug 7, 2026
Richard Blumenthal
D· SENATE· ALPHA TEKNOVA INC
SELL$1,001 - $15,000Sep 1, 2026(26d)
Aug 6, 2026
Richard Blumenthal
D· SENATE· ALPHA TEKNOVA INC
SELL$1,001 - $15,000Sep 1, 2026(27d)
Aug 6, 2026
Richard Blumenthal
D· SENATE· ALPHA TEKNOVA INC
SELL$15,001 - $50,000Sep 1, 2026(27d)

Insider ledger

Form 4
$143.4K
bought · 2 insiders
$0
sold · 0 insiders
+196.6%
vs their $2.17 cost
DateInsiderTypeValue
Jul 14, 2026
DEMSKI MARTHA J
Director
OTHER12,000 sh
Jun 1, 2026
DEMSKI MARTHA J
Director
AWARD55,000 sh
Jun 1, 2026
ROBERTSON BRETT
Director
AWARD55,000 sh
Jun 1, 2026
Vos Alexander
Director
AWARD55,000 sh
Mar 6, 2026
Lowell Matthew
Chief Financial Officer
BUY$87.6K
Mar 6, 2026
Gunstream Stephen
President and CEO
BUY$55.8K
Feb 15, 2026
Gunstream Stephen
President and CEO
AWARD429,000 sh
Feb 15, 2026
Lowell Matthew
Chief Financial Officer
AWARD171,000 sh

Earnings setup

Estimates
Nov 4
reports in 9 days
−$0.07
EPS estimate, this quarter
+15%
estimate change, 90 days
4↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.07-$0.07–-$0.07+5.8%$11.8M
Next Q-$0.08-$0.09–-$0.08+3.7%$11.1M
Current FY-$0.29-$0.31–-$0.28+2.1%$46.0M
Next FY-$0.19-$0.19–-$0.19+5.0%$52.7M

Short side

FINRA· Sep 30, 2026
1,634,663
shares short
+3.5%
vs prior settlement
4.8
days to cover
≈3.0%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 21, 2026 SEC
Alpha Teknova, Inc. announced it will report its Q3 2026 results on November 4, 2026.
PRESS-RELEASE — Impact 1/10
Oct 21, 2026 Earnings
Teknova to Report Third Quarter 2026 Financial Results on November 4, 2026
HOLLISTER, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO),
Oct 21, 2026 SEC
Alpha Teknova priced a $40M underwritten public offering of 8M shares at $5.00/share (closing Oct 22), concurrently…
8-K — Impact 6/10
Oct 21, 2026 SEC
Alpha Teknova priced an underwritten public offering of 8,000,000 shares of common stock at $5.00 per share, raising…
424B5 — Impact 6/10
Oct 20, 2026 Press
Alpha Teknova has announced an underwritten public offering of its common stock, with an additional 15% option for…
Impact 5/10
Aug 12, 2026 Congress
Richard Blumenthal sell
$1,001 - $15,000 — Senate
Aug 12, 2026 Congress
Richard Blumenthal sell
$1,001 - $15,000 — Senate
Jul 14, 2026 Insider
DEMSKI MARTHA J disposed of 12,000 shares
Director
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent
Oct 21, 2026
Earnings
Teknova to Report Third Quarter 2026 Financial Results on November 4, 2026
HOLLISTER, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for…
Oct 20, 2026
Activist
Teknova Announces Proposed Public Offering of Common Stock
HOLLISTER, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for…
Oct 20, 2026
Earnings
Teknova Announces Preliminary Third Quarter Financial Results
HOLLISTER, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for…
Oct 2, 2026
Press release
Teknova and Pluristyx Announce FDA Drug Master File for the PluriFreeze™ Cryopreservation System
Teknova and Pluristyx announce a Type II FDA Drug Master File for the PluriFreeze™ cryopreservation system, now available to developers for…
Sep 16, 2026
Press release
Teknova Expands Custom Manufacturing with Fill-Tek™ Dispensing System for Flexible Single-Use Bag Filling
Teknova's Fill-Tek™ Dispensing System fills single-use bag orders across multiple sizes and quantities as a single lot, with no added turnaround time.

SecBot reports

9 filings · 1 press release · 2 bullish · 2 bearish · 2 mixed · 3 neutral
All TKNO filing & press-release reports (10)